Back to Drug index

Back to Narcotic Analgesics

Brand Name: Pethidine
Name: Meperidine

	Percutaneous in-situ coronary venous arterialization is a new less invasive alternative to CABG.
	send to a friend   printer friendly version
	discuss this article
	Related   Transesophageal echo: uses, techniques and complications Cardiology Discussion board

Pregnancy Category B

Drug classes
Narcotic agonist analgesic

Mechanism of action of Pethidine
Acts as agonist at specific opioid receptors in the CNS to produce analgesia, euphoria, sedation; the receptors mediating these effects are thought to be the same as those mediating the effects of endogenous opioids (enkephalins, endorphins).

Indications of Pethidine

1. Relief of moderate to severe pain (oral, parenteral)
2. Preoperative medication, support of anesthesia, and obstetric analgesia
   (parenteral)

Contraindications of Pethidine

1. Presence of hypersensitivity to narcotics,
2. Diarrhea caused by poisoning (before toxins are eliminated)
3. Bronchial asthma, COPD, cor pulmonale, respiratory depression, anoxia
4. Kyphoscoliosis
5. Acute alcoholism
6. Increased intracranial pressure
7. Pregnancy

Use caution in the presence of acute abdominal conditions, cardiovascular disease, supraventricular tachycardias, myxedema, convulsive disorders, delirium tremens, cerebral arteriosclerosis, ulcerative colitis, fever, Addison's disease, prostatic hypertrophy, urethral stricture, recent GI or GU surgery, toxic psychosis, labor or delivery (administration of narcotics, including meperidine, to the mother can cause respiratory depression of neonate; premature infants are especially at risk), renal or hepatic dysfunction.

		Are you a doctor or a nurse? Do you want to join the Doctors Lounge online medical community? Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients. Click on the link below to see the requirements: Doctors Lounge Membership Application

Adverse effects of Pethidine

May produce less intense smooth muscle spasm, less constipation, less cough reflex suppression than equianalgesic doses of morphine.

• CNS: Lightheadedness, dizziness, sedation, euphoria, dysphoria, delirium, insomnia, agitation, anxiety, fear, hallucinations, disorientation, drowsiness, lethargy, impaired mental and physical performance, coma, mood changes, weakness, headache, tremor, convulsions, miosis, visual disturbances, suppression of cough reflex
• GI: Nausea, vomiting, dry mouth, anorexia, constipation, biliary tract spasm, increased colonic motility in patients with chronic ulcerative colitis
• CV: Facial flushing, peripheral circulatory collapse, tachycardia, bradycardia, arrhythmia, palpitations, chest wall rigidity, hypertension, hypotension, orthostatic hypotension, syncope
• GU: Ureteral spasm, spasm of vesical sphincters, urinary retention or hesitancy, oliguria, antidiuretic effect, reduced libido or potency
• Dermatologic: Pruritus, urticaria, laryngospasm, bronchospasm, edema
  Local: tissue irritation and induration (SC injection)
• Major hazards: Respiratory depression, apnea, circulatory depression, respiratory arrest, shock, cardiac arrest
• Other: Sweating, physical tolerance and dependence, psychological dependence

send to a friend printer friendly version

The Rheumatology Discussion Board     Rheumatology Topics             The Rheumatology Articles